Literature DB >> 29395620

High throughput gene sequencing reveals altered landscape in DNA damage responses and chromatin remodeling in sporadic pancreatic neuroendocrine tumors.

Shunrong Ji1, Wenting Yang2, Jiang Liu1, Jingjing Zhao2, Liang Chen2, Quanxing Ni1, Jiang Long3, Xianjun Yu4.   

Abstract

PURPOSE: The main objectives of this retrospective study were to survey the genetic landscape of PNETs in a clinical cohort by using the high throughput gene sequencing method and to determine cellular signaling networks affected by the uncovered gene mutations.
MATERIALS AND METHODS: We retrieved the demographics and tumor characteristics of 13 patients. Cellular DNA was extracted from fresh snap frozen tumor tissues and was subject to high throughput gene sequencing analysis using the Illumina NextSeq500 System. Furthermore, the interaction network was constructed from the input gene set by Reactome and performed gene set enrichment analysis was performed with a cutoff FDR of ≤0.01.
RESULTS: Totally 74 mutated genes and 93 mutations were identified. The median number of mutations was 7 (range 1-20) and that of mutated genes was 6 (range 1-17). Among these mutations, 48 (51.6%) were substitution mutations, nine (9.7%) were duplication mutations, 28 (30.1%) were deletion mutations and eight (8.6%) were deletion/insertion mutations. Gene set enrichment analysis generated a network of 21 interactions, 10 of which were associated with DNA repair like the Fanconi anemia pathway, nucleotide excision repair, and homologous recombination repair, or chromosome maintenance. Moreover, 9 patients had one or more mutations in DNA repair genes including the mismatch repair genes MSH2/MSH6.
CONCLUSIONS: The study has uncovered genetic alterations of genes implicated in DNA damage responses and chromatin remodeling. Our findings will prompt further studies into the role of these mutated genes in the oncogenesis and molecular stratification of PNETs.
Copyright © 2018 IAP and EPC. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Genetic; Neuroendocrine tumor; Pancreas; Pathway; Sequencing

Mesh:

Year:  2018        PMID: 29395620     DOI: 10.1016/j.pan.2018.01.006

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  3 in total

1.  Identification of new candidate genes and signalling pathways associated with the development of neuroendocrine pancreatic tumours based on next generation sequencing data.

Authors:  Oleg I Kit; Vladimir S Trifanov; Nataliya A Petrusenko; Dmitry Y Gvaldin; Denis S Kutilin; Nataliya N Timoshkina
Journal:  Mol Biol Rep       Date:  2020-05-25       Impact factor: 2.742

2.  Integrated analysis highlights multiple long non‑coding RNAs and their potential roles in the progression of human esophageal squamous cell carcinoma.

Authors:  Cheng-Yun Li; Wen-Wen Zhang; Ji-Lian Xiang; Xing-Hua Wang; Jun-Ling Wang; Jin Li
Journal:  Oncol Rep       Date:  2019-10-17       Impact factor: 3.906

3.  Evolutionary Trajectories of Primary and Metastatic Pancreatic Neuroendocrine Tumors Based on Genomic Variations.

Authors:  Midie Xu; Jiuliang Yan; Beiyuan Hu; Chuntao Wu; Haitao Gu; Zihao Qi; Tao Chen; Wenting Yang; Yan Zheng; Hanguang Dong; Weiqi Sheng; Jiang Long
Journal:  Genes (Basel)       Date:  2022-09-04       Impact factor: 4.141

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.